HomeMBIO • NASDAQ
add
Mustang Bio Inc
Nakaraang pagsara
$2.05
Sakop ng araw
$1.18 - $1.36
Sakop ng taon
$0.89 - $31.00
Market cap
5.38M USD
Average na Volume
1.07M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 253.00K | -95.16% |
Net na kita | -153.00K | 97.05% |
Net profit margin | — | — |
Kita sa bawat share | — | — |
EBITDA | -219.00K | 95.57% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 14.23M | 964.40% |
Kabuuang asset | 14.91M | 2.17% |
Kabuuang sagutin | 11.30M | -42.16% |
Kabuuang equity | 3.61M | — |
Natitirang share | 4.38M | — |
Presyo para makapag-book | 1.92 | — |
Return on assets | -5.22% | — |
Return on capital | -206.03% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -153.00K | 97.05% |
Cash mula sa mga operasyon | -1.39M | 73.90% |
Cash mula sa pag-invest | 1.16M | — |
Cash mula sa financing | 7.62M | 15,442.86% |
Net change in cash | 7.39M | 240.21% |
Malayang cash flow | 6.88K | 100.21% |
Tungkol
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
Itinatag
2015
Headquarters
Website
Mga Empleyado
6
